文献速递糖尿病

瑞典全国注册研究:1型与2型糖尿病心血管事件及死亡风险差异

Risk differences and underlying factors of cardiovascular events and mortality in patients with type 2 diabetes versus type 1 diabetes: a longitudinal cohort study of Swedish nationwide register data.
PubMed 文献 · Lancet Diabetes Endocrinol · 2025-08-25

病程较长可能是1型糖尿病风险较高的主要因素。

要点

  • 2型糖尿病年轻患者(<50岁)心血管风险高于1型,老年患者(>60岁)风险低于1型。
  • 1型糖尿病总体心血管事件和全因死亡风险高于2型,尤其60岁以上人群。
  • 病程较长是1型糖尿病风险较高的主要因素,强化管理可改变危险因素。

核心结论

  • 1型糖尿病总体心血管事件和全因死亡风险高于2型糖尿病,尤其在60岁以上人群。
  • 2型糖尿病在50岁以下人群心血管复合终点风险高于1型。
  • 病程较长可能是1型糖尿病风险较高的主要因素。

研究设计与样本

  • 使用Cox回归分析,调整年龄、性别及多种心血管危险因素,并与无糖尿病匹配对照比较。

主要发现

  • 调整多种心血管危险因素后,2型糖尿病相比1型糖尿病风险更高;但排除糖尿病病程后,1型糖尿病风险更高。

临床怎么用

  • 应重视2型糖尿病年轻患者(<50岁)的心血管风险,尤其心力衰竭。
  • 对1型糖尿病老年患者(>60岁)需加强心血管危险因素管理。
  • 糖尿病病程较长者心血管风险更高,应强化可改变危险因素的综合管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite improvements in diabetes care and risk factor management, the residual risk for cardiovascular disease and premature death remains substantially elevated in people both with type 1 and type 2 diabetes. This study aimed to compare the risk of cardiovascular disease and mortality, as well as the contibution of underlying risk factors, between type 1 and type 2 diabetes. METHODS: In this nationwide, population-based cohort study, all living people with diabetes aged 18-84 years reported in the Swedish National Diabetes Register (NDR) by Jan 1, 2016, were followed-up over a period of 5 years until Dec 31, 2020. Data from the National Patient Register, including all inpatient and outpatient hospital visits, were used to compare the incidence of major cardiovascular disease events (myocardial infarction, heart failure onset or exacerbation, stroke, and cardiovascular death) and all-cause death, also in different age groups. Baseline data were collected from NDR and other national registers. Cox regression analyses, adjusted for age and sex, as well as for multiple cardiovascular risk factors were performed. In addition, the type 1 diabetes and type 2 diabetes cohorts were compared with matched control groups with no diabetes. FINDINGS: 404 026 adults with type 1 diabetes (38 351 [9·5%]) or type 2 diabetes (365 675 [90·5%]) were included. Individuals with type 2 diabetes had a higher risk than individuals with type 1 diabetes for the composite endpoint of any cardiovascular disease event (HR 1·23, 95% CI 1·07-1·41) at ages younger than 50 years but a lower risk at ages older than 60 years (0·87, 0·82-0·92). A similar pattern was observed for myocardial infarction (0·67, 0·61-0·73) and all-cause mortality (0·89, 0·84-0·95) in ages older than 60 years. However, the risk for stroke was overall lower in type 2 diabetes (0·91, 0·84-0·98, all ages combined), whereas for heart failure it was higher at ages younger than 50 years (1·60, 1·15-2·21). Among people with previous cardiovascular disease, those with type 2 diabetes overall had a lower risk versus type 1 diabetes for all cardiovascular disease (0·76, 0·70-0·81), for myocardial infarction (0·62, 0·56-0·70), cardiovascular mortality (0·68, 0·61-0·75) and all-cause mortality (0·71, 0·66-0·77). In analyses adjusting for multiple cardiovascular risk factors, the whole cohort with type 2 diabetes had a greater risk for incident cardiovascular disease and mortality compared with type 1 diabetes. However, when diabetes duration was excluded from the model, type 1 diabetes was associated with higher risk. Compared with matched controls, both diabetes types were associated with greater risk for the studied outcomes, but this was most marked for type 1 diabetes. INTERPRETATION: In this study, type 1 diabetes was associated with higher overall risk for cardiovascular disease events and all-cause mortality than type 2 diabetes, particularly at ages older than 60 years for the studied outcomes. Longer diabetes duration seems to be a main contributing factor for higher risk found in people with type 1 diabetes versus those with type 2 diabetes in this age group. Enhanced management of all modifiable risk factors could help prevent cardiovascular disease and premature death in both type 1 and type 2 diabetes. FUNDING: Swedish Heart and Lung Foundation, Swedish Research Council, and ALF grants at the Uppsala University Hospital.

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Patsoukaki V, Lind L, Lampa E, et al. Risk differences and underlying factors of cardiovascular events and mortality in patients with type 2 diabetes versus type 1 diabetes: a longitudinal cohort study of Swedish nationwide register data. Lancet Diabetes Endocrinol. 2025. PMID: 40876474. doi:10.1016/S2213-8587(25)00165-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。